© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 05, 2018
Legislators and a libertarian think-tank have flaunted the merits of the Right-to-Try experimental drug policy. But physicians question its value and the message it sends to patients.
Emily Strouphauer, BSA: Linking Pediatric Psoriasis to Anxiety, Depression
Raj Chovatiya, MD, PhD: Psoriasis Treatment Developments, FDA Approvals in 2022
Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis